NORTH TIDE CAPITAL, LLC

Average Profitability
42.65%
Insider Buys Quantity
5
Insider Buys Sum
$19.37M
Insider Sells Quantity
11
Insider Sells Sum
$69.79M

Insider Activity of NORTH TIDE CAPITAL, LLC

The largest purchase of all time was on 2014-05-08 and amounted to 748000 shares of Amedisys, Inc. for $10.52M.

The largest sale of all time was on 2015-11-03 and amounted to 435160 shares of Amedisys, Inc. for $17.37M.

Biography of NORTH TIDE CAPITAL, LLC

No biography is available at this moment.

2015-11-03SaleAmedisys, Inc.
AMED
10 percent owner
435,160
1.3118%
$39.93$17.37M+18.15%
2015-11-02SaleAmedisys, Inc.
AMED
10 percent owner
187,640
0.5604%
$40.07$7.52M+16.63%
2015-10-30SaleAmedisys, Inc.
AMED
10 percent owner
293,800
0.8855%
$39.61$11.64M+19.53%
2015-10-29SaleAmedisys, Inc.
AMED
10 percent owner
74,000
0.2237%
$39.83$2.95M+19%
2015-10-28SaleAmedisys, Inc.
AMED
10 percent owner
270,000
0.8128%
$40.09$10.82M+17.5%
2015-10-26SaleAmedisys, Inc.
AMED
10 percent owner
112,800
0.3414%
$39.32$4.44M+20.44%
2015-06-29SaleSelect Medical Holdings Corporation
SEM
10 percent owner
154,500
0.1225%
$16.29$2.52M-25.67%
2015-06-26SaleSelect Medical Holdings Corporation
SEM
10 percent owner
295,500
0.2335%
$16.62$4.91M-27.31%
2015-03-10SaleSelect Medical Holdings Corporation
SEM
10 percent owner
133,100
0.1041%
$12.98$1.73M-4.46%
2015-03-09SaleSelect Medical Holdings Corporation
SEM
10 percent owner
336,300
0.2633%
$13.38$4.5M-7.09%
2014-08-11SaleSelect Medical Holdings Corporation
SEM
10 percent owner
100,000
0.079%
$14.00$1.4M+2.98%
2014-08-11PurchaseSelect Medical Holdings Corporation
SEM
10 percent owner
100,000
0.079%
$14.00$1.4M+2.98%
2014-05-08PurchaseAmedisys, Inc.
AMED
10 percent owner
748,000
2.4405%
$14.06$10.52M+87.87%
2014-05-07PurchaseAmedisys, Inc.
AMED
10 percent owner
252,000
0.7785%
$13.45$3.39M+85.74%
2014-05-01PurchaseAmedisys, Inc.
AMED
10 percent owner
87,000
0.2725%
$13.60$1.18M+84.25%
2014-04-30PurchaseAmedisys, Inc.
AMED
10 percent owner
213,000
0.6552%
$13.52$2.88M+71.42%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.